Here are the 10-Q quarterly reports from DuPont de Nemours, Inc. (DD) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow DD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DD filings page.
DuPont de Nemours, Inc. (DD) reported third-quarter 2026 net sales of $1.868 billion, compared with $1.795 billion a year earlier, and income from continuing operations of $171 million, versus $102 million. Net income available for DuPont common stockholders was $123 million, compared with a $123 million loss.
For the nine months ended September 30, 2026, income from continuing operations was $512 million versus $206 million, while cash provided by continuing operating activities was $1.042 billion versus $473 million. At September 30, 2026, cash and cash equivalents were $1.652 billion and long-term debt was $3.094 billion.
DuPont completed the Aramids business sale on April 1, 2026, in a transaction for gross consideration of $1.8 billion. At closing, it received approximately $1.2 billion in pre-tax cash proceeds, a $300 million note receivable, and an approximately 16% non-controlling common equity interest in Arclin valued at $325 million. DuPont recorded a total $378 million loss on the sale, including an $82 million gain recognized in the second quarter when the disposal group's carrying value was finalized. The Aramids and previously separated Electronics businesses are presented as discontinued operations.
DuPont de Nemours, Inc. reported Q2 2026 net sales of $1,819 million, up from $1,749 million a year earlier. Income from continuing operations rose to $191 million, or basic EPS of $1.38, compared with $24 million and $0.17. Net income attributable to common stockholders was $143 million.
For the first six months, net sales were $3,500 million and operating cash provided by continuing operations increased to $632 million from $151 million, supporting cash and cash equivalents of $1,740 million and long-term debt of $3,125 million at June 30, 2026.
On April 1, 2026 DuPont completed the $1.8 billion Aramids business divestiture, receiving approximately $1.2 billion in cash, a $300 million note receivable and a 16 percent equity interest valued at $325 million; Aramids and the previously separated Electronics business are presented as discontinued operations.
DuPont continues to address legacy PFAS matters under a Memorandum of Understanding with Chemours and Corteva. Indemnification liabilities accrued under this framework and related litigation were $530 million at June 30, 2026, including a $188 million accrual for the proposed $875 million New Jersey settlement and a $125 million liability related to State of North Carolina matters. A 1-for-3 reverse stock split became effective June 24, 2026, leaving 135,042,975 shares outstanding at July 31, 2026.
DuPont de Nemours, Inc. reports higher profitability for the quarter ended March 31, 2026 while continuing a major portfolio reshaping. Net sales from continuing operations rose to $1.681 billion from $1.612 billion, and income from continuing operations increased to $150 million from $80 million.
Including discontinued operations, net income was $164 million, compared with a net loss of $(581) million a year earlier that was driven by large Aramids goodwill impairment and separation-related charges. Discontinued operations contributed $14 million of income versus a $(661) million loss in 2025.
On April 1, 2026 DuPont closed the Aramids business divestiture for gross consideration of $1.8 billion, receiving about $1.2 billion in cash, a $300 million note and a non‑controlling equity stake valued at $325 million. The Aramids and prior Electronics businesses are reported as discontinued operations. DuPont also launched a $80 million restructuring program in 2026 and is seeking shareholder approval for a reverse stock split at a 1‑for‑2 to 1‑for‑4 ratio, with a corresponding reduction in authorized shares. Environmental and PFAS‑related indemnification liabilities and reserves remain significant but are subject to cost‑sharing arrangements and proposed long‑term settlements.
DuPont de Nemours (DD) reported Q3 2025 results and major portfolio moves. Net sales were $3,072 million, up from $2,862 million. Income from continuing operations was $308 million, but a loss from discontinued operations of $415 million drove a net loss of $107 million, or diluted EPS of $-0.29. EPS from continuing operations was $0.70.
The company completed the spin-off of its Electronics business into Qnity on November 1, 2025, with those results to be shown as discontinued operations starting in Q4. DuPont also agreed to sell its Aramids business for gross consideration of $1.8 billion, including approximately $1.2 billion in cash, a $300 million note and a $325 million minority equity interest; Aramids is classified as held for sale and recorded a $437 million loss from classification to held for sale in Q3.
Cash, cash equivalents and restricted cash totaled $3,826 million at period end, including $1,830 million of restricted cash largely tied to Qnity notes in escrow. Long‑term debt was $7,049 million. DuPont prepaid $56 million toward the Sinochem (Ningbo) RO Memtech acquisition, which closed October 10, 2025.
DuPont de Nemours, Inc. (DD) Q2-25 10-Q highlights
- Net sales rose 2.7% YoY to $3.26 bn; six-month sales up 3.6% to $6.32 bn.
- Continuing ops profitability improved: operating EPS (basic) $0.54 vs $0.40; operating income before tax $306 m vs $296 m.
- Discontinued ops drag: $168 m loss in Q2 and $202 m YTD tied largely to PFAS-related MOU and New Jersey litigation.
- Bottom line: Q2 net income fell 62% to $70 m; GAAP EPS $0.14 vs $0.43. 1H-25 shows $512 m loss, driven by a $768 m goodwill impairment on Aramids reporting unit.
- Cash flow: 1H operating cash $763 m (-25% YoY); capex $365 m; free cash flow ≈$398 m.
- Balance sheet: Cash $1.84 bn, debt $7.18 bn (ST & LT); equity $23.5 bn; net leverage ~0.2× EBITDA (company data).
- Strategic actions: targeting 1 Nov 2025 spin-off of ElectronicsCo (to be named Qnity Electronics); 2025 segment realignment now reports ElectronicsCo and IndustrialsCo separately.
- Restructuring: $49 m charges YTD for separation-related program (target $100 m through 2026); 2023-24 program largely complete.
- Legal & tax: PFAS cost-sharing and New Jersey matters continue; effective tax rate Q2 22.2% vs 40.5%.
Outlook: Management reiterates separation timeline; near-term focus on margin expansion, cash generation and litigation management.